Development of an in vitro blood-brain barrier model based on immortalized porcine brain microvascular endothelial cells

Farmaco

Volumn 59, Issue 2, 2004, Pages 133-137

  Lauer, Regina ^a   Bauer, Roland ^a   Linz, Birgit ^b   Pittner, Fritz ^a   Peschek, Guenther A ^a   Ecker, Gerhard ^a   Friedl, Peter ^c   Noe, Christian R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b GOETHE UNIVERSITY   (Germany)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Benzodiazepines; Blood brain barrier; Immortalized porcine brain microvascular endothelial cells; In vitro model

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOBAZAM; DIAZEPAM; NORCLOBAZAM;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL IMMORTALIZATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG PENETRATION; ENDOTHELIUM CELL; GLIOMA CELL; IN VITRO STUDY; MEASUREMENT; MICROVASCULATURE; MODEL; NONHUMAN; RAT;

EID: 1042302113     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2003.11.007     Document Type: Article

References (30)

1. Pardridge W.M. Blood-brain barrier methodology and biology. Pardridge W.M. Introduction to the Blood-Brain Barrier. 1998;1-8 Cambridge University Press, Cambridge.
2. Joo F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 48:1996;255-273.
3. Pardridge W.M. Brain metabolism: a perspective from the blood-brain barrier. Physiol. Rev. 63:1983;1481-1535.
4. Ayrton A., Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 31:2001;469-497.
5. Tsuji A., Tamai I. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv. Drug Deliv. Rev. 36:1999;277-290.
6. Pardridge W.M. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug Deliv. Rev. 15:1995;5-36.
7. Tamai I., Tsuji A. Drug delivery through the blood-brain barrier. Adv. Drug Deliv. Rev. 19:1996;401-424.
8. Tsuji A., Tamai I. Blood-brain barrier function of P-glycoprotein. Adv. Drug Deliv. Rev. 25:1997;287-298.
9. Suzuki H., Terasaki T., Sugiyama Y. Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system. Adv. Drug Deliv. Rev. 25:1997;257-285.
10. Pardridge W.M. Blood-brain barrier biology and methodology. J. Neuroviol. 5:1999;556-569.
11. Butt A.M. Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anaesthetized rats. Brain Res. 696:1995;145-150.
12. Bauer R., Lauer R., Linz B., Pittner F., Peschek G.A., Ecker G.F., et al. An in vitro model for blood-brain barrier permeation. Sci. Pharm. 70:2002;317-324.
13. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 325:1987;253-257.
14. Meresse S., Dehouck M.P., Delorme P., Bensaid M., Tauber J.P., Delbart C., et al. Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J. Neurochem. 53:1989;1363-1371.
15. Gaillard P.J., van der Sandt I.C.J., Voorwinden L.H., Vu D., Nielsen J.L., de Boer A.G., et al. Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm. Res. 17:2000;1198-1205.
16. De Boer A.G., Gaillard P.J. In Vitro Models of the Blood-Brain Barrier: when to use which? Central nervous system agents. Curr. Med. Chem. 2:2002;203-209.
17. Buchstaller H.P., Siebert C.D., Lyssy R.H., Ecker G., Krug M., Berger M.L., et al. Thieno[2,3-b]pyridones as antagonists on the glycine site of the N-methyl-D-aspartate Receptor-binding studies, molecular modeling and structure-activity relationships. Sci. Pharm. 68:2000;3-14.
18. Berger M.L., Schödl C., Noe C.R. Inverse agonists at the polyamine-sensitive modulatory site of the NMDA receptor: 50-fold increase in potency by insertion of an aromatic ring into an alkanediamine chain. Eur. J. Med. Chem. 33:1998;3-14.
19. Teifl M., Friedl P. Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. Exp. Cell Res. 228:1996;50-57.
20. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differential rat glial cell strain in tissue culture. Science. 161:1968;370-371.
21. Siflinger-Birnboim A., Del Vecchio P.J., Cooper J.A., Blumenstock F.A., Shepard J.N., Malik A.B. Molecular sieving characteristics of the cultured endothelial monolayer. J. Cell Physiol. 132:1987;111-117.
22. Scifinder Scholar 2002, Cheminal Abstracts Service, American Chemical Society.
23. Molecular Operating Environment (MOE), Chemical Computing Group, Montreal, Canada.
24. Ertl P., Rohde B., Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43:2000;3714-3717.
25. Halleux C., Schneider Y.-J. Iron absorption by intestinal epithelial cells. 1.) Caco 2 cells cultivated in serum-free medium, on polyethylenterephtalate microporous membranes, as an in vitro model. In Vitro Cell. Dev. Biol. 27A:1991;293.
26. Dehouck M.-P., Jolliet-Riant P., Bree F., Fruchart J.-C., Cecchelli R., Tillement J.-P. Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo modells. J. Neurochem. 58:1992;1790-1797.
27. Shah M.V., Audus K.L., Borchardt R.T. The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm. Res. 6:1989;624-627.
28. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buee-Scherrer V., Duhem C., et al. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Del. 36:1999;165-178.
29. Ecker G.F., Noe C.R. In silico prediction models for blood-brain barrier permeation. Curr. Med. Chem. 2004;. [in press].
30. Kelder J., Grootenhuis P.D.J., Bayada D.M., Delbressine L.P.C., Ploemen J.P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 16:1999;1514-1519.